From: Responsiveness of the EuroQoL 5-Dimension (EQ-5D) questionnaire in patients with spondyloarthritis
At follow-up | Â | % (n) | EQ-5D scores | Change of EQ-5D scores | p-valuea | EQ-VAS | Change of EQ-VAS | p-valuea | ||
---|---|---|---|---|---|---|---|---|---|---|
Baseline | Follow-up | Baseline | Follow-up | |||||||
Change of treatment | Yes | 13.2% (20) | 0.76 (0.21) | 0.75 (0.26) | -0.03 (0.13) | 0.742 | 64.75 (19.27) | 65.25 (21.18) | 0.50 (17.06) | 0.870 |
No | 86.8% (131) | 0.80 (0.18) | 0.80 (0.17) | 0.00 (0.11) | 63.74 (17.85) | 65.12 (17.70) | 1.42 (21.10) | |||
Change of biologics | Yes | 2.6% (4) | 0.71 (0.29) | 0.81 (0.06) | -0.05 (0.11) | 0.459 | 58.00 (32.29) | 63.75 (24.96) | 5.75 (14.57) | 0.644 |
No | 97.4% (147) | 0.80 (0.18) | 0.79 (0.19) | 0.00 (0.11) | 64.03 (17.60) | 65.18 (18.01) | 1.18 (20.72) | |||
Change of NSAIDs/COX-2 Inhibitors | Yes | 1.3% (2) | 0.71 (0.24) | 0.75 (0.28) | 0.04 (0.04) | 0.236 | 52.50 (24.75) | 55.00 (21.21) | 2.50 (3.54) | 0.889 |
No | 98.7% (149) | 0.80 (0.18) | 0.79 (0.18) | 0.00 (0.11) | 64.03 (17.94) | 65.28 (18.12) | 1.28 (20.70) | |||
Change of DMARDs | Yes | 2.0% (3) | 0.81 (0.10) | 0.87 (0.05) | 0.10 (0.14) | 0.262 | 66.67 (15.28) | 66.67 (20.82) | 0.00 (10.00) | 0.835 |
No | 98.0% (148) | 0.80 (0.18) | 0.79 (0.19) | -0.01 (0.11) | 63.82 (18.07) | 65.11 (18.14) | 1.33 (20.73) | |||
Addition of NSAIDs/COX-2 Inhibitors | Yes | 2.0% (3) | 0.72 (0.38) | 0.59 (0.61) | -0.13 (0.23) | 0.340 | 65.67 (13.65) | 86.67 (7.64) | 21.00 (8.54) | 0.039* |
No | 98.0% (148) | 0.80 (0.18) | 0.80 (0.16) | 0.00 (0.11) | 63.84 (18.09) | 64.70 (18.01) | 0.90 (20.55) | |||
Addition of DMARDs | Yes | 2.0% (3) | 0.90 (0.06) | 0.91 (0.04) | 0.03 (0.04) | 0.579 | 78.33 (7.64) | 56.67 (32.15) | -21.67 (25.66) | 0.081 |
No | 98.0% (148) | 0.79 (0.18) | 0.79 (0.18) | 0.00 (0.11) | 63.58 (18.02) | 65.31 (17.87) | 1.77 (20.28) | |||
Addition of biologics | Yes | 4.0% (6) | 0.76 (0.14) | 0.72 (0.11) | -0.05 (0.06) | 0.123 | 66.00 (16.31) | 65.83 (18.55) | -0.17 (10.68) | 0.672 |
No | 96.0% (145) | 0.80 (0.18) | 0.80 (0.19) | 0.00 (0.12) | 63.78 (18.10) | 65.11 (18.17) | 1.36 (20.89) |